Press Releases

February 21, 2025

Invitation to Presentation of Egetis’ Fourth Quarter and Year-End 2024 Report on February 26, 2025

Read more

February 20, 2025

Egetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease Day

Read more

Regulatory

February 13, 2025

European Commission approves Egetis’ Emcitate® (tiratricol) as the first and only treatment for patients with MCT8 deficiency

Read more

Upcoming event

Calendar and upcoming reports

February 26, 2025

Year-end Report Q4 2024 (7:00am CET)

March 12, 2025

Carnegie Nordic Healthcare Conference (Stockholm)

April 2, 2025

Van Lanschot Kempen Life Sciences Conference (Amsterdam)

April 30, 2025

Interim Report Q1 2025 (7:00am CEST)

May 6, 2025

Annual General Meeting

Joshua’s Story